Find any stock by ticker or company name
Barcha huquqlar himoyalangan.
5.83
0.00 (0.00%)
Vitalhub continues executing its M&A-driven growth strategy, surpassing $100M ARR and restoring EBITDA margins as integrations near completion. Organic growth remains around 10%, supplemented by acquisitions, while cross-selling integrated solutions is emerging as a key organic driver. The company's valuation at 16x EV/EBITDA, down from 25x, offers an attractive entry point.
Vitalhub TSE: VHI reported second-quarter 2026 revenue of CAD 31.7 million, up 33% from the prior-year period, while annual recurring revenue surpassed CAD 100 million for the first time.
Vitalhub Corp. (VHI:CA) Q2 2026 Earnings Call Transcript
TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (“VitalHub” or the “Company”) announced today that the Toronto Stock Exchange (the "Exchange") has accepted a notice filed by VitalHub of its intention to make a Normal Course Issuer Bid (the "Bid") to be transacted through the facilities of the Exchange or through alternative Canadian trading systems.
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 28% YoY to $101.5 million Total Revenue up 33% YoY to $31.7 million Adjusted EBITDA⁽¹⁾ up 29% YoY to $8.2 million
There is no data to display
